Film creditsThe total is not the available fraction.
Investigate how phases, micelles and membranes distribute an ingredient before attributing behaviour to its nominal concentration.
Proposed programme | Application, materials, capacity and rights to be qualified.
Count the places a molecule can occupy.
A formula’s total concentration can be distributed between water, oil, interfaces, micelles and carrier membranes.
A formula’s total concentration can be distributed between water, oil, interfaces, micelles and carrier membranes. The fraction relevant to an observed response may differ from the nominal amount on the ingredient sheet. A formulator deciding whether to change an oil or surfactant needs to know which distribution matters to the development question.
The proposed investigation treats phase distribution as a testable hypothesis. It might explain a change in release, extraction or chemical exposure. The first task is to identify the possible compartments and an analytical operation that can resolve them without creating a new equilibrium that obscures the original formulation.
Examine the development decision
The total is not the available fraction.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Read a binding result in its own conditions.
Fugit and Anderson (2014) investigated membrane binding and release in liposomes, showing that partition behaviour and transport need to be considered together.
Fugit and Anderson (2014) investigated membrane binding and release in liposomes, showing that partition behaviour and transport need to be considered together. Their study is an external pharmaceutical example; its coefficients belong to the tested compound, lipid system and experimental conditions.
Liu et al. (2009) examined free benzalkonium chloride in micellar systems and reported dependence on surfactant and medium. That abstract-level evidence supports the importance of free-fraction measurement, not a preservative recommendation for a Bio product. An application brief would recover the relevant phase and assay information before considering whether either study provides an appropriate method analogy.
A deliberately simple balance.
For an ideal two-phase equilibrium, total active mass can be expressed as aqueous concentration multiplied by water volume plus oil concentration multiplied by oil volume.
For an ideal two-phase equilibrium, total active mass can be expressed as aqueous concentration multiplied by water volume plus oil concentration multiplied by oil volume. Introducing an oil-to-water concentration ratio gives the displayed estimate for aqueous concentration. It is useful because every assumption is visible.
The model excludes micelles, interfacial adsorption, ionisation, precipitation and concentration-dependent binding. Many real formulations contain those features. A reader could change phase volumes and a stated partition coefficient to understand why the same total loading can imply a different free concentration, while the page explicitly keeps that illustration separate from a validated prediction for the finished formula.
Mass-balance illustration for two ideal equilibrated liquid phases.
- aqueous-phase concentrationmg mL⁻¹
- total active massmg
- aqueous volumemL
- oil volumemL
- oil-to-water concentration ratio C_o/C_w1
Model conditions. Equilibrium; fixed volumes; linear distribution; positive denominator. No micelles, binding, adsorption, precipitation, reaction or speciation.
The carrier and its contribution.
Compare a structured carrier with a simpler vehicle around loading, availability, handling and the intended formulation.
Whether the assay changes the answer?
Ultrafiltration can remove carriers but also bind active; dilution can change micellar populations; centrifugation may leave smaller entities in the sampled fraction.
Ultrafiltration can remove carriers but also bind active; dilution can change micellar populations; centrifugation may leave smaller entities in the sampled fraction. The proposed method record would state what each operation excludes and include active-recovery controls. An apparently free fraction is operationally defined until independent checks support the assignment.
Wallace et al. (2012) identify incomplete particle separation as a source of inaccurate encapsulation and release estimates. That warning applies to the interpretation of phase fractions. The report would preserve the separation history and distinguish a measured filtrate concentration from a claim about chemical activity at an interface or biological site.
Change the conditions · examine the reference
The total is not the available fraction.
Change pH and phase volume. See how a defined neutral species can redistribute even when total loading stays constant.
The data, equations and controls remain available below if 3D cannot load.
Defined model · illustrative conditions
Move a control to compare the selected condition with the defined reference curve.
Separate total loading from phase-specific concentration before defining a functional comparison.
The defined comparison
Hypothetical monoprotic weak acid: pKₐ = 4.8, neutral-species partition ratio K = [HA]oil/[HA]water = 10, total 1 mmol per litre of whole formulation. Only neutral HA partitions into oil; phase volumes are additive and activities ideal. No micelles, adsorption, binding or non-equilibrium behaviour. Phase shares refer to solute mass, not liquid volume. This reference does not predict preservation efficacy, microbial safety or delivery to skin.
Inspect the calculated values
Calculation grid, not measured observations. Inputs and assumptions are stated above.
| Aqueous pH / dimensionless | Aqueous neutral solute | Aqueous ionised solute | Neutral solute in oil |
|---|
Keeping pH and association in the same map.
For an ionisable compound, changing pH can alter both partition behaviour and solubility.
For an ionisable compound, changing pH can alter both partition behaviour and solubility. A pH adjustment might also change carrier surface interactions. The proposed comparison would therefore record pH, buffer composition and phase volumes together rather than treating a supplier partition coefficient as a universal material constant.
Luengo et al. (2021) investigated a local-pH mechanism in a PLGA system. That provides a useful counterexample to the idea that all delivery changes arise from physical transport of a carrier. The buyer’s active requires its own chemistry and measurements; the proposed programme would investigate competing explanations before recommending a more elaborate architecture.
Connecting distribution to the decision.
A cosmetic development team may need the active to remain chemically protected in one phase during storage but become available during application.
A cosmetic development team may need the active to remain chemically protected in one phase during storage but become available during application. That is a trade-off between retention and availability, with different relevant conditions. The optimal total loading cannot be chosen independently of phase distribution and the function being investigated.
The proposed paid output is a compartment map, a method-readiness record and a bounded comparison of the preparation variables that can change the next decision. A later formulation evaluation could investigate whether the intended distribution persists after incorporation. No partition model alone establishes safety, skin efficacy, preservation or an available Bio delivery technology.
The phase changes that matter.
An opening discussion should identify the active grade, oils, surfactants, pH range, final base and current analytical approach.
An opening discussion should identify the active grade, oils, surfactants, pH range, final base and current analytical approach. The most useful first check may be recovery of free active through the proposed separation method, or solubility across a realistic phase-composition change. That check can determine whether a more complex study is warranted.
A meaningful milestone would be a reproducible phase-accounting observation that changes a formulation choice. If the method cannot resolve the needed fraction, the deliverable should say so and identify a qualified alternative. The commercial invitation is a precise decision about distribution and its consequence, not an unexplained ranking of delivery systems.
The next proposed comparison.
Partition-and-speciation evidence record with an operational free-fraction method.
Colloidal delivery · Proposed development discussion
A development path
for this research.
Which formulation phase controls the active’s free concentration and the application-relevant driving force?
The people this could serve.Formulation, ingredient and application development teams.
The decision behind the project.
Your intended application, present alternative and the constraint behind “Partitioning and free activity”. A useful starting point is the change that would justify another development step.
A proposed scope centred on partition-and-speciation evidence record with an operational free-fraction method.
Agree the comparison, acceptance basis and responsible expertise before discussing a paid package.
Specialist methods and a defined contribution.
Bring relevant analytical or experimental expertise, a comparator suggestion, and the conditions under which your method could resolve this question.
A jointly scoped proposal could connect your contribution with partition-and-speciation evidence record with an operational free-fraction method.
Define contributions, required access, independent preparations and permitted outputs before work or protected information is shared.
The commercial purpose of the next milestone.
Bring the application or asset thesis, the buyer you expect to value it, and the scientific or commercial uncertainty that must be resolved before another commitment.
The proposed decision record would connect the buyer question with partition-and-speciation evidence record with an operational free-fraction method. It would identify what a subsequent comparison needs to demonstrate.
Demand, development cost, resources, rights and a decision-changing milestone would need examination. No financing terms or investment outcome are represented here.
What a useful comparison
would record.
- Record aqueous-phase concentration (mg mL⁻¹) with the preparation, method and conditions needed to interpret it.
- Record total active mass (mg) with the preparation, method and conditions needed to interpret it.
- Record aqueous volume (mL) with the preparation, method and conditions needed to interpret it.
What the proposed
brief could leave behind.
- Partition-and-speciation evidence record with an operational free-fraction method
- A preparation, comparator and endpoint record tied to this question.
- A source-linked account of the evidence gaps, study assumptions and next review point.
The proposed discussion brief
A brief you
can take away.
Use non-confidential notes to connect this topic with your own decision. Entries stay in this browser tab; saving creates a text file on your device. Nothing is submitted.
Scoped paid evidence brief, then separately qualified comparison; evaluation or licensing only after reproducibility, capacity and rights review.
Notes are optional. The brief includes this page’s proposed question and public source links.
Proposed scope; resources, methods, rights and delivery terms would be agreed before work. Begin with non-confidential information.
Sources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
Fugit and Anderson, 2014Fugit and Anderson (2014) Dynamic, Nonsink Method for the Simultaneous Determination of Drug Permeability and Binding Coefficients in Liposomes
Release depends on liposome binding, volumes, transport and chosen sink conditions.
Scope and limitations: Public author manuscript XML inspected; ACS copyright retained. Brief paraphrase only, no figure/data redistribution or automatic commercial source licence.
Open original sourceLiu et al, 2009Liu et al. (2009) Determination of benzalkonium chloride partition in micelle solutions using ultrafiltration method
Free preservative depends on surfactant and medium; separation approaches compared.
Scope and limitations: Abstract-level evidence only. Pharmaceutical preservative/micellar context; no preservation pass, permitted cosmetic dose or finished-product safety inference.
Open original sourceWallace et al, 2012Wallace et al. (2012) Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology
Separation efficiency and scattering checks before release/encapsulation interpretation.
Scope and limitations: Abstract-level scope only. No quantitative result or figure reused; full methods review needed before any study design is commissioned.
Open original sourceLuengo et al, 2021Luengo et al. (2021) Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes
Carrier degradation, local pH, ionisation and controls in flufenamic-acid/caffeine skin experiments.
Scope and limitations: CC BY 4.0 full XML inspected. Specific acidic-drug study; no general particle passage, product efficacy or permission for Bio human-use work.
Open original source